(Q83179196)
Statements
Single-dose pegfilgrastim is comparable to daily filgrastim in mobilizing peripheral blood stem cells: a case-matched study in patients with lymphoproliferative malignancies (English)
Mervi Putkonen
Tarja-Terttu Pelliniemi